Long-term IOP lowering with bimatoprost in open-angle glaucoma patients poorly responsive to latanoprost

Journal of Ocular Pharmacology and Therapeutics

Volumn 24, Issue 5, 2008, Pages 517-520

  Sonty, Sriram ^a,b   Donthamsetti, Vikrant ^b   Vangipuram, Gautam ^b   Ahmad, Afzal ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Midwest Eye Center SC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIMATOPROST; BRIMONIDINE; BRINZOLAMIDE; DORZOLAMIDE; LATANOPROST; PILOCARPINE; PROSTAGLANDIN DERIVATIVE; TIMOLOL; TRAVOPROST;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLEPHARITIS; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONJUNCTIVAL HYPEREMIA; CONTROLLED STUDY; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EYE DISEASE; FEMALE; FOLLOW UP; HUMAN; HYPERTRICHOSIS; INTRAOCULAR PRESSURE; LONG TERM CARE; MALE; MONOTHERAPY; OPEN ANGLE GLAUCOMA; OUTCOME ASSESSMENT; PIGMENT DISORDER; PIGMENT EPITHELIUM; RETINA MACULA CYSTOID EDEMA; SIDE EFFECT; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UVEITIS;

AGED; AMIDES; ANTIHYPERTENSIVE AGENTS; CLOPROSTENOL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; OPHTHALMIC SOLUTIONS; PILOT PROJECTS; PROSTAGLANDINS F, SYNTHETIC; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 52449108423     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2008.0033     Document Type: Article

References (16)

1. Quigley, H.A., and Broman, A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90:262-267, 2006.
2. Lindsey, J.D., Kashiwagi, K., Kashiwagi, F., et al. Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro. Invest. Ophthalmol. Vis. Sci. 38:2214-2223, 1997.
3. Weinreb, R.N., and Lindsey, J.D. Metalloproteinase gene transcription in human ciliary muscle cells with latanoprost. Invest. Ophthalmol. Vis. Sci. 43:716-722, 2002.
4. Wan, Z., Woodward, D.F., Cornell, C.L., et al. Bimatoprost, prostamide activity, and conventional drainage. Invest. Ophthalmol. Vis. Sci. 48:4107-4115, 2007.
5. Brubaker, R.F. Mechanism of action of bimatoprost (Lumigan). Surv. Ophthalmol. 45(Suppl 4):S347-S351, 2001.
6. Walters, T.R., DuBiner, H.B., Carpenter, S.P., et al. 24-hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: A 1-month, randomized, comparative clinical trial. Surv. Ophthalmol. 49(Suppl 1):S26-S35, 2004.
7. Noecker, R.S., Dirks, M.S., Choplin, N.T., et al. A six-month, randomized, clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am. J. Ophthalmol. 135:55-63, 2003.
8. Gandolfi, S., Simmons, S.T., Sturm, R., et al. Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Adv. Ther. 18:110-121, 2001.
9. Parrish, R.K., Palmberg, P., and Sheu, W.P. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: A 12-week, randomized, masked-evaluator multicenter study. Am. J. Ophthalmol. 135:688-703, 2003.
10. Martinez, A., and Sanchez, M. Intraocular pressure-lowering effect of dorzolamide/timolol fixed combination in patients with glaucoma who were unresponsive to prostaglandin analogs/prostamides. Curr. Med. Res. Opin. 23:595-599, 2007.
11. Williams, R.D. Efficacy of bimatoprost in glaucoma and ocular hypertension unresponsive to latanoprost. Adv. Ther. 19:275-281, 2002.
12. Gandolfi, S.A., and Cimino, L. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost. Ophthalmology 110:609-614, 2003.
13. Hollo, G. The side effects of the prostaglandin analogues. Exp. Opin. Drug Safety 6:45-52, 2007.
14. Law, S.K., Song, B.J., Fang, E., et al. Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid health maintenance organization. Ophthalmology 112:2123-2130, 2005.
15. McCarney, R., Warner, J., Iliffe, S., et al. The Hawthorne effect: A randomised, controlled trial. BMC Med. Res. Methodol. 7:30, 2007.
16. Gupta, V., Srinivasan, G., Sharma, A., et al. Comparative evaluation of bimatoprost monotherapy in primary chronic angle closure and primary open-angle glaucoma eyes: A three-year study. J. Ocul. Pharmacol. Ther. 23:351-358, 2007.